Cargando…
A Metabolomics Approach to Stratify Patients Diagnosed with Diabetes Mellitus into Excess or Deficiency Syndromes
The prevalence of type 2 diabetes continuously increases globally. The traditional Chinese medicine (TCM) can stratify the diabetic patients based on their different TCM syndromes and, thus, allow a personalized treatment. Metabolomics is able to provide metabolite biomarkers for disease subtypes. I...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4312632/ https://www.ncbi.nlm.nih.gov/pubmed/25667595 http://dx.doi.org/10.1155/2015/350703 |
_version_ | 1782355145039806464 |
---|---|
author | Wu, Tao Yang, Ming Liu, Tao Yang, Lili Ji, Guang |
author_facet | Wu, Tao Yang, Ming Liu, Tao Yang, Lili Ji, Guang |
author_sort | Wu, Tao |
collection | PubMed |
description | The prevalence of type 2 diabetes continuously increases globally. The traditional Chinese medicine (TCM) can stratify the diabetic patients based on their different TCM syndromes and, thus, allow a personalized treatment. Metabolomics is able to provide metabolite biomarkers for disease subtypes. In this study, we applied a metabolomics approach using an ultraperformance liquid chromatography (UPLC) coupled with quadruple-time-of-flight (QTOF) mass spectrometry system to characterize the metabolic alterations of different TCM syndromes including excess and deficiency in patients diagnosed with diabetes mellitus (DM). We obtained a snapshot of the distinct metabolic changes of DM patients with different TCM syndromes. DM patients with excess syndrome have higher serum 2-indolecarboxylic acid, hypotaurine, pipecolic acid, and progesterone in comparison to those patients with deficiency syndrome. The excess patients have more oxidative stress as demonstrated by unique metabolite signatures than the deficiency subjects. The results provide an improved understanding of the systemic alteration of metabolites in different syndromes of DM. The identified serum metabolites may be of clinical relevance for subtyping of diabetic patients, leading to a personalized DM treatment. |
format | Online Article Text |
id | pubmed-4312632 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-43126322015-02-09 A Metabolomics Approach to Stratify Patients Diagnosed with Diabetes Mellitus into Excess or Deficiency Syndromes Wu, Tao Yang, Ming Liu, Tao Yang, Lili Ji, Guang Evid Based Complement Alternat Med Research Article The prevalence of type 2 diabetes continuously increases globally. The traditional Chinese medicine (TCM) can stratify the diabetic patients based on their different TCM syndromes and, thus, allow a personalized treatment. Metabolomics is able to provide metabolite biomarkers for disease subtypes. In this study, we applied a metabolomics approach using an ultraperformance liquid chromatography (UPLC) coupled with quadruple-time-of-flight (QTOF) mass spectrometry system to characterize the metabolic alterations of different TCM syndromes including excess and deficiency in patients diagnosed with diabetes mellitus (DM). We obtained a snapshot of the distinct metabolic changes of DM patients with different TCM syndromes. DM patients with excess syndrome have higher serum 2-indolecarboxylic acid, hypotaurine, pipecolic acid, and progesterone in comparison to those patients with deficiency syndrome. The excess patients have more oxidative stress as demonstrated by unique metabolite signatures than the deficiency subjects. The results provide an improved understanding of the systemic alteration of metabolites in different syndromes of DM. The identified serum metabolites may be of clinical relevance for subtyping of diabetic patients, leading to a personalized DM treatment. Hindawi Publishing Corporation 2015 2015-01-18 /pmc/articles/PMC4312632/ /pubmed/25667595 http://dx.doi.org/10.1155/2015/350703 Text en Copyright © 2015 Tao Wu et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Wu, Tao Yang, Ming Liu, Tao Yang, Lili Ji, Guang A Metabolomics Approach to Stratify Patients Diagnosed with Diabetes Mellitus into Excess or Deficiency Syndromes |
title | A Metabolomics Approach to Stratify Patients Diagnosed with Diabetes Mellitus into Excess or Deficiency Syndromes |
title_full | A Metabolomics Approach to Stratify Patients Diagnosed with Diabetes Mellitus into Excess or Deficiency Syndromes |
title_fullStr | A Metabolomics Approach to Stratify Patients Diagnosed with Diabetes Mellitus into Excess or Deficiency Syndromes |
title_full_unstemmed | A Metabolomics Approach to Stratify Patients Diagnosed with Diabetes Mellitus into Excess or Deficiency Syndromes |
title_short | A Metabolomics Approach to Stratify Patients Diagnosed with Diabetes Mellitus into Excess or Deficiency Syndromes |
title_sort | metabolomics approach to stratify patients diagnosed with diabetes mellitus into excess or deficiency syndromes |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4312632/ https://www.ncbi.nlm.nih.gov/pubmed/25667595 http://dx.doi.org/10.1155/2015/350703 |
work_keys_str_mv | AT wutao ametabolomicsapproachtostratifypatientsdiagnosedwithdiabetesmellitusintoexcessordeficiencysyndromes AT yangming ametabolomicsapproachtostratifypatientsdiagnosedwithdiabetesmellitusintoexcessordeficiencysyndromes AT liutao ametabolomicsapproachtostratifypatientsdiagnosedwithdiabetesmellitusintoexcessordeficiencysyndromes AT yanglili ametabolomicsapproachtostratifypatientsdiagnosedwithdiabetesmellitusintoexcessordeficiencysyndromes AT jiguang ametabolomicsapproachtostratifypatientsdiagnosedwithdiabetesmellitusintoexcessordeficiencysyndromes AT wutao metabolomicsapproachtostratifypatientsdiagnosedwithdiabetesmellitusintoexcessordeficiencysyndromes AT yangming metabolomicsapproachtostratifypatientsdiagnosedwithdiabetesmellitusintoexcessordeficiencysyndromes AT liutao metabolomicsapproachtostratifypatientsdiagnosedwithdiabetesmellitusintoexcessordeficiencysyndromes AT yanglili metabolomicsapproachtostratifypatientsdiagnosedwithdiabetesmellitusintoexcessordeficiencysyndromes AT jiguang metabolomicsapproachtostratifypatientsdiagnosedwithdiabetesmellitusintoexcessordeficiencysyndromes |